UnitedHealth's newly returned CEO, Stephen Hemsley, will likely face investor scrutiny over the largest U.S. health insurance and services company's efforts to rein in the elevated medical costs behind the withdrawal of its annual forecast.

UnitedHealth has been the Dow’s worst performer of 2025, but jumped 13% Friday. Here’s why Buffett and other leading hedge funds suddenly love the stock.

Berkshire’s Big Bet on UnitedHealth Berkshire Hathaway’s (NYSE:BRK-A)(NYSE:BRK-B) release yesterday of its latest 13F filing sent ripples through the market as it revealed a new 5 million share stake in UnitedHealth Group (NYSE:UNH) worth approximately $1.

UnitedHealth Group announced yet another major executive move this week, with Chief Financial Officer John Rex set to step down next month. | UnitedHealth Group announced yet another major executive move this week,

Wayne DeVeydt will take over as CFO of UnitedHealth effective Sept. 2, according to securities filings. He replaces John Rex, who has been in the role since 2016. Shares of UnitedHealth dropped around .60% early Friday.

UnitedHealth's yield is typically less than 2%, but nowadays, it's well over 3%. The stock experienced a steep decline in value this year as its financials underwhelmed investors. Rising costs, utilization rates,

Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008.

UnitedHealth CEO Stephen J. Hemsley responded. QUESTION: "What happens to United in the event that reform doesn't happen? How are you positioned to succeed?"

Even though Warren Buffett seems to think the value of UnitedHealth stock is about right, that doesn’t mean investors should ignore the long list of unresolved issued facing the company.